TG Therapeutics Inc vs VICI Properties Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while VICI Properties Inc trades at $26.66 (market cap $29.55B). The key difference: VICI Properties Inc is far larger — about 3.6× TG Therapeutics Inc's market cap, and VICI Properties Inc pays a 6.71% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VICI | |
|---|---|---|
Market Cap | $8.26B | $29.55B |
Sector | Health | Real Estate |
52-Week High | $59.06 | $33.93 |
52-Week Low | $26.39 | $25.94 |
Enterprise Value | $8.50B | $46.77B |
Dividend Yield | — | 6.71% |
Trailing returns across standard periods
Latest headlines on both assets
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →